Applications
Application Search for UHPLC & HPLC
| Classification | Data name | Compound name | Product code | Column | |
| Pharmaceuticals, Drugs, Metabolites | Tadalafil | Tadalafil | KBN99S05-2546WT | CHIRAL ART Amylose-C (Neo) | |
| Pharmaceuticals, Drugs, Metabolites | Sterols | Brassicasterol Cholesterol Fucosterol Stigmasterol Campesterol β-Sitosterol | JM08S04-2546WT | J'sphere ODS-M80 | |
| Pharmaceuticals, Drugs, Metabolites | Ibrutinib | Ibrutinib | KCN99S05-2546WT | CHIRAL ART Cellulose-C | |
| Pharmaceuticals, Drugs, Metabolites | Sterols | Brassicasterol Cholesterol Fucosterol Stigmasterol Campesterol β-Sitosterol | AL12S05-2546WT | YMC-Pack ODS-AL | |
| Pharmaceuticals, Drugs, Metabolites | Galantamine | Galantamine | KBN99S05-2546WT | CHIRAL ART Amylose-C (Neo) | |
| Pharmaceuticals, Drugs, Metabolites | The right HIC column for each separation: BioPro HIC HT and BioPro HIC BF | Adalimumab (Humira®) Trastuzumab (Herceptin®) | BHB00S04-1046WT | BioPro HIC BF | |
| Pharmaceuticals, Drugs, Metabolites | LC/MS analysis of tetracycline antibiotics | Oxytetracycline Tetracycline Chlortetracycline Doxycycline | TA12S05-0502WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Sterols | Brassicasterol Cholesterol Fucosterol Stigmasterol Campesterol β-Sitosterol | JM08S04-2546WT | J'sphere ODS-M80 | |
| Pharmaceuticals, Drugs, Metabolites | RP vs. HILIC: Fast UHPLC analysis of biomarkers related to tobacco smoke exposure using YMC-Triart C18 and YMC-Triart Diol-HILIC | 7-Methylguanine (m7Gua) 8-Hydroxy-2’-deoxyguanosine (8-OHdG) (-)-Nicotine (-)-Cotinine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) | TDH12SP9-10Q1PT | YMC-Triart Diol-HILIC | |
| Pharmaceuticals, Drugs, Metabolites | Levocarnitine injection(L-Carnitine injection) | Levocarnitine chloride (L-Carnitine chloride) Levocarnitine impurity A | TDH12S05-1546WT | YMC-Triart Diol-HILIC | |
| Pharmaceuticals, Drugs, Metabolites | Cephalosporin antibiotics | Cefsulodin sodium Cephalexin hydrate Cefaclor Cephradine Cephaloglycin Cephapirin sodium Cefotaxime sodium Cephaloridine Cefazolin sodium Cefuroxime sodium Cefoxitin sodium | JM08S04-2546WT | J'sphere ODS-M80 | |
| Pharmaceuticals, Drugs, Metabolites | Erythromycin antibiotic drugs | Erythromycin Erythromycin ethylsuccinate Erythromycin estolate | TA12S03-0502WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Cephalosporin antibiotics | Cefsulodin sodium Cephalexin hydrate Cefaclor Cephradine Cephaloglycin Cephapirin sodium Cefotaxime sodium Cephaloridine Cefazolin sodium Cefuroxime sodium Cefoxitin sodium | JL08S04-2546WT | J'sphere ODS-L80 | |
| Pharmaceuticals, Drugs, Metabolites | Clindamycin hydrochloride (The United States Pharmacopoeia) | Lincomycin hydrochloride Clindamycin hydrochloride | TA12S05-2546WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Cephalosporin antibiotics | Cefsulodin sodium Cephalexin hydrate Cefaclor Cephradine Cephaloglycin Cephapirin sodium Cefotaxime sodium Cephaloridine Cefazolin sodium Cefuroxime sodium Cefoxitin sodium | JH08S04-2546WT | J'sphere ODS-H80 | |
| Pharmaceuticals, Drugs, Metabolites | Bepotastine | Bepotastine | KSA99S05-2546WT | CHIRAL ART Amylose-SA | |
| Pharmaceuticals, Drugs, Metabolites | Clindamycin hydrochloride (The Japanese Pharmacopoeia 15th Edition Supplement II) | Clindamycin hydrochloride | TA12S05-2546WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Cephalosporin antibiotics | Cephaloglycin Cefotaxime sodium Cephapirin sodium | JM08S04-L546WT | J'sphere ODS-M80 | |
| Pharmaceuticals, Drugs, Metabolites | Esomeprazole | Esomeprazole | KSC99S05-2546WT | CHIRAL ART Cellulose-SC | |
| Pharmaceuticals, Drugs, Metabolites | Barbiturates | Barbital Phenobarbital Hexobarbital Pentobarbital Secobarbital | TA12S05-0502WT | YMC-Triart C18 |
